NuPathe Inc (NASDAQ:PATH) jumped 41.52 percent to $3.25 in the current trading session following the news that Endo Health Solutions is acquiring NuPathe in a deal valued at roughly $105 million. NuPathe shareholders will receive $2.85 for each share that indicates a premium of 24 percent from the stock’s closing price on Friday. PATH has a market capitalization of $101.82 […]
[at noodls] – Gelclair Launch Expected to Provide Additional Commercial Revenue for DARA in 2013 RALEIGH, NC and LUGANO, SWITZERLAND — (Marketwired) — 04/22/13 — DARA BioSciences, Inc. (NASDAQ: DARA), a specialty … moreView todays social media effects on DARAView the latest stocks trending across Twitter. Click to view dashboardSee who DARA is hiring next, click here to view […]
moreView todays social media effects on DARAView the latest stocks trending across Twitter. Click to view dashboardSee who DARA is hiring next, click here to view […]
[at noodls] – RALEIGH, N.C. , March 1, 2013 – DARA BioSciences, Inc. (NASDAQ: DARA) (the Company or DARA), announced today the appointments of Haywood D. Cochrane Jr. as chairman of the DARA … moreView todays social media effects on DARAView the latest stocks trending across Twitter. Click to view dashboardSee who DARA is hiring next, click here to view […]
[ACN Newswire] – By Jake KingDARA BioSciences (NASDAQ:DARA) released some much-needed positive news Monday morning, reporting the domestic launch of Soltamox, the first oral, liquid formulation of the breast-cancer drug … moreView todays social media effects on DARAView the latest stocks trending across Twitter. Click to view dashboard […]
